Edwards Lifesciences Corp vs Johnson & Johnson
EW vs JNJ — side-by-side comparison from reported financials. EW leads 1, JNJ leads 9 of 10 comparable metrics.
Edwards Lifesciences Corp
EW · Healthcare
$85.21+1.15%Strong
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | EW | JNJ |
|---|---|---|
| Price | $85.21 | $261.79 |
| Market cap | $49.1B | $631B |
| Revenue (TTM) | $6.51B | $97.9B |
| Revenue growth | +4.1% | +5.6% |
| Net margin | 15.4% | 21.5% |
| Free cash flow | $1.43B | $22.2B |
| Net cash (debt) | $3.63B | ($27.8B) |
| 1-year price return | +13.3% | +37.0% |
| P/E | 48.9 | 29.9 |
| P/E vs own history (cheap-side %) | 11% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 10% | 26% |
| Altman Z-score | 11.86 | — |
| CV checks passed | 9 of 10 | 10 of 10 |
| Employees | 16,000 | 140,800 |
Full résumé-style profiles: EW CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.